nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—UGT1A1—Estradiol—osteoporosis	0.0547	0.0805	CbGbCtD
Lovastatin—ABCC2—Ethinyl Estradiol—osteoporosis	0.0517	0.076	CbGbCtD
Lovastatin—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0457	0.0673	CbGbCtD
Lovastatin—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0431	0.0635	CbGbCtD
Lovastatin—SLCO1A2—Estradiol—osteoporosis	0.0402	0.059	CbGbCtD
Lovastatin—ABCC2—Conjugated Estrogens—osteoporosis	0.0379	0.0558	CbGbCtD
Lovastatin—SLCO1B1—Estradiol—osteoporosis	0.0379	0.0557	CbGbCtD
Lovastatin—CYP2C9—Estropipate—osteoporosis	0.0269	0.0396	CbGbCtD
Lovastatin—CYP2C8—Raloxifene—osteoporosis	0.0258	0.0379	CbGbCtD
Lovastatin—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0249	0.0366	CbGbCtD
Lovastatin—CYP3A7—Estradiol—osteoporosis	0.0222	0.0327	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0222	0.0327	CbGbCtD
Lovastatin—CYP2C8—Cholecalciferol—osteoporosis	0.0199	0.0292	CbGbCtD
Lovastatin—ABCB1—Ethinyl Estradiol—osteoporosis	0.0168	0.0248	CbGbCtD
Lovastatin—CYP2C19—Cholecalciferol—osteoporosis	0.0167	0.0245	CbGbCtD
Lovastatin—CYP3A5—Estradiol—osteoporosis	0.0167	0.0245	CbGbCtD
Lovastatin—CYP2C8—Estradiol—osteoporosis	0.016	0.0236	CbGbCtD
Lovastatin—CYP3A4—Estropipate—osteoporosis	0.0157	0.023	CbGbCtD
Lovastatin—CYP3A4—Calcitriol—osteoporosis	0.0157	0.023	CbGbCtD
Lovastatin—CYP2C9—Cholecalciferol—osteoporosis	0.0139	0.0204	CbGbCtD
Lovastatin—CYP2C19—Estradiol—osteoporosis	0.0134	0.0198	CbGbCtD
Lovastatin—CYP2D6—Cholecalciferol—osteoporosis	0.0127	0.0187	CbGbCtD
Lovastatin—CYP3A4—Ergocalciferol—osteoporosis	0.0125	0.0184	CbGbCtD
Lovastatin—ABCB1—Conjugated Estrogens—osteoporosis	0.0124	0.0182	CbGbCtD
Lovastatin—CYP2C9—Estradiol—osteoporosis	0.0112	0.0164	CbGbCtD
Lovastatin—ABCB1—Estradiol—osteoporosis	0.0109	0.016	CbGbCtD
Lovastatin—CYP3A4—Raloxifene—osteoporosis	0.0104	0.0154	CbGbCtD
Lovastatin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0101	0.0148	CbGbCtD
Lovastatin—CYP3A4—Cholecalciferol—osteoporosis	0.00807	0.0119	CbGbCtD
Lovastatin—CYP3A4—Conjugated Estrogens—osteoporosis	0.00741	0.0109	CbGbCtD
Lovastatin—CYP3A4—Estradiol—osteoporosis	0.0065	0.00956	CbGbCtD
Lovastatin—HDAC2—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000911	1	CbGdCrCtD
Lovastatin—Abdominal pain—Alendronate—osteoporosis	0.000277	0.00131	CcSEcCtD
Lovastatin—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000277	0.00131	CcSEcCtD
Lovastatin—Sinusitis—Estradiol—osteoporosis	0.000277	0.00131	CcSEcCtD
Lovastatin—Discomfort—Pamidronate—osteoporosis	0.000275	0.00131	CcSEcCtD
Lovastatin—Angioedema—Zoledronate—osteoporosis	0.000273	0.0013	CcSEcCtD
Lovastatin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000273	0.00129	CcSEcCtD
Lovastatin—Abdominal pain—Raloxifene—osteoporosis	0.000272	0.00129	CcSEcCtD
Lovastatin—Body temperature increased—Raloxifene—osteoporosis	0.000272	0.00129	CcSEcCtD
Lovastatin—Vision blurred—Conjugated Estrogens—osteoporosis	0.000271	0.00129	CcSEcCtD
Lovastatin—Urticaria—Ibandronate—osteoporosis	0.000271	0.00128	CcSEcCtD
Lovastatin—Malaise—Zoledronate—osteoporosis	0.00027	0.00128	CcSEcCtD
Lovastatin—Body temperature increased—Ibandronate—osteoporosis	0.00027	0.00128	CcSEcCtD
Lovastatin—Abdominal pain—Ibandronate—osteoporosis	0.00027	0.00128	CcSEcCtD
Lovastatin—Confusional state—Pamidronate—osteoporosis	0.000269	0.00128	CcSEcCtD
Lovastatin—Vertigo—Zoledronate—osteoporosis	0.000269	0.00127	CcSEcCtD
Lovastatin—Leukopenia—Zoledronate—osteoporosis	0.000268	0.00127	CcSEcCtD
Lovastatin—Anaphylactic shock—Pamidronate—osteoporosis	0.000267	0.00127	CcSEcCtD
Lovastatin—Infection—Pamidronate—osteoporosis	0.000265	0.00126	CcSEcCtD
Lovastatin—Urticaria—Calcitriol—osteoporosis	0.000265	0.00126	CcSEcCtD
Lovastatin—Hepatitis—Estradiol—osteoporosis	0.000265	0.00125	CcSEcCtD
Lovastatin—Body temperature increased—Calcitriol—osteoporosis	0.000264	0.00125	CcSEcCtD
Lovastatin—Abdominal pain—Calcitriol—osteoporosis	0.000264	0.00125	CcSEcCtD
Lovastatin—Angioedema—Conjugated Estrogens—osteoporosis	0.000263	0.00125	CcSEcCtD
Lovastatin—Hypersensitivity—Estropipate—osteoporosis	0.000262	0.00124	CcSEcCtD
Lovastatin—Thrombocytopenia—Pamidronate—osteoporosis	0.000262	0.00124	CcSEcCtD
Lovastatin—Vomiting—Etidronic acid—osteoporosis	0.000261	0.00124	CcSEcCtD
Lovastatin—Rash—Etidronic acid—osteoporosis	0.000259	0.00123	CcSEcCtD
Lovastatin—Dermatitis—Etidronic acid—osteoporosis	0.000259	0.00123	CcSEcCtD
Lovastatin—Vertigo—Conjugated Estrogens—osteoporosis	0.000259	0.00123	CcSEcCtD
Lovastatin—Hypersensitivity—Alendronate—osteoporosis	0.000258	0.00122	CcSEcCtD
Lovastatin—Headache—Etidronic acid—osteoporosis	0.000257	0.00122	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000256	0.00121	CcSEcCtD
Lovastatin—Asthenia—Estropipate—osteoporosis	0.000255	0.00121	CcSEcCtD
Lovastatin—Anorexia—Pamidronate—osteoporosis	0.000255	0.00121	CcSEcCtD
Lovastatin—Arthralgia—Zoledronate—osteoporosis	0.000255	0.00121	CcSEcCtD
Lovastatin—Myalgia—Zoledronate—osteoporosis	0.000255	0.00121	CcSEcCtD
Lovastatin—Chest pain—Zoledronate—osteoporosis	0.000255	0.00121	CcSEcCtD
Lovastatin—Insomnia—Risedronate—osteoporosis	0.000254	0.0012	CcSEcCtD
Lovastatin—Anxiety—Zoledronate—osteoporosis	0.000254	0.0012	CcSEcCtD
Lovastatin—Paraesthesia—Risedronate—osteoporosis	0.000252	0.0012	CcSEcCtD
Lovastatin—Pruritus—Estropipate—osteoporosis	0.000252	0.00119	CcSEcCtD
Lovastatin—Discomfort—Zoledronate—osteoporosis	0.000251	0.00119	CcSEcCtD
Lovastatin—Asthenia—Alendronate—osteoporosis	0.000251	0.00119	CcSEcCtD
Lovastatin—Hypersensitivity—Ibandronate—osteoporosis	0.000251	0.00119	CcSEcCtD
Lovastatin—Dyspnoea—Risedronate—osteoporosis	0.000251	0.00119	CcSEcCtD
Lovastatin—Erythema multiforme—Estradiol—osteoporosis	0.00025	0.00119	CcSEcCtD
Lovastatin—Dry mouth—Zoledronate—osteoporosis	0.000249	0.00118	CcSEcCtD
Lovastatin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000248	0.00118	CcSEcCtD
Lovastatin—Pruritus—Alendronate—osteoporosis	0.000248	0.00117	CcSEcCtD
Lovastatin—Dyspepsia—Risedronate—osteoporosis	0.000247	0.00117	CcSEcCtD
Lovastatin—Constipation—Ethinyl Estradiol—osteoporosis	0.000246	0.00117	CcSEcCtD
Lovastatin—Confusional state—Zoledronate—osteoporosis	0.000246	0.00117	CcSEcCtD
Lovastatin—Hypersensitivity—Calcitriol—osteoporosis	0.000246	0.00117	CcSEcCtD
Lovastatin—Flushing—Estradiol—osteoporosis	0.000246	0.00116	CcSEcCtD
Lovastatin—Chest pain—Conjugated Estrogens—osteoporosis	0.000245	0.00116	CcSEcCtD
Lovastatin—Myalgia—Conjugated Estrogens—osteoporosis	0.000245	0.00116	CcSEcCtD
Lovastatin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000245	0.00116	CcSEcCtD
Lovastatin—Asthenia—Ibandronate—osteoporosis	0.000245	0.00116	CcSEcCtD
Lovastatin—Anxiety—Conjugated Estrogens—osteoporosis	0.000244	0.00116	CcSEcCtD
Lovastatin—Nausea—Etidronic acid—osteoporosis	0.000244	0.00116	CcSEcCtD
Lovastatin—Anaphylactic shock—Zoledronate—osteoporosis	0.000244	0.00116	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000243	0.00115	CcSEcCtD
Lovastatin—Diarrhoea—Estropipate—osteoporosis	0.000243	0.00115	CcSEcCtD
Lovastatin—Infection—Zoledronate—osteoporosis	0.000242	0.00115	CcSEcCtD
Lovastatin—Fatigue—Risedronate—osteoporosis	0.000242	0.00115	CcSEcCtD
Lovastatin—Insomnia—Pamidronate—osteoporosis	0.000242	0.00115	CcSEcCtD
Lovastatin—Pruritus—Ibandronate—osteoporosis	0.000241	0.00114	CcSEcCtD
Lovastatin—Pain—Risedronate—osteoporosis	0.00024	0.00114	CcSEcCtD
Lovastatin—Constipation—Risedronate—osteoporosis	0.00024	0.00114	CcSEcCtD
Lovastatin—Paraesthesia—Pamidronate—osteoporosis	0.00024	0.00114	CcSEcCtD
Lovastatin—Diarrhoea—Alendronate—osteoporosis	0.00024	0.00114	CcSEcCtD
Lovastatin—Asthenia—Calcitriol—osteoporosis	0.000239	0.00114	CcSEcCtD
Lovastatin—Thrombocytopenia—Zoledronate—osteoporosis	0.000239	0.00113	CcSEcCtD
Lovastatin—Dyspnoea—Pamidronate—osteoporosis	0.000238	0.00113	CcSEcCtD
Lovastatin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000237	0.00113	CcSEcCtD
Lovastatin—Chills—Estradiol—osteoporosis	0.000237	0.00113	CcSEcCtD
Lovastatin—Pruritus—Calcitriol—osteoporosis	0.000236	0.00112	CcSEcCtD
Lovastatin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000236	0.00112	CcSEcCtD
Lovastatin—Diarrhoea—Raloxifene—osteoporosis	0.000236	0.00112	CcSEcCtD
Lovastatin—Dyspepsia—Pamidronate—osteoporosis	0.000235	0.00111	CcSEcCtD
Lovastatin—Dizziness—Estropipate—osteoporosis	0.000235	0.00111	CcSEcCtD
Lovastatin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000235	0.00111	CcSEcCtD
Lovastatin—Alopecia—Estradiol—osteoporosis	0.000234	0.00111	CcSEcCtD
Lovastatin—Infection—Conjugated Estrogens—osteoporosis	0.000233	0.00111	CcSEcCtD
Lovastatin—Diarrhoea—Ibandronate—osteoporosis	0.000233	0.00111	CcSEcCtD
Lovastatin—Anorexia—Zoledronate—osteoporosis	0.000233	0.0011	CcSEcCtD
Lovastatin—Decreased appetite—Pamidronate—osteoporosis	0.000232	0.0011	CcSEcCtD
Lovastatin—Dizziness—Alendronate—osteoporosis	0.000232	0.0011	CcSEcCtD
Lovastatin—Fatigue—Pamidronate—osteoporosis	0.00023	0.00109	CcSEcCtD
Lovastatin—Gastrointestinal pain—Risedronate—osteoporosis	0.00023	0.00109	CcSEcCtD
Lovastatin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000229	0.00109	CcSEcCtD
Lovastatin—Pain—Pamidronate—osteoporosis	0.000228	0.00108	CcSEcCtD
Lovastatin—Constipation—Pamidronate—osteoporosis	0.000228	0.00108	CcSEcCtD
Lovastatin—Diarrhoea—Calcitriol—osteoporosis	0.000228	0.00108	CcSEcCtD
Lovastatin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000228	0.00108	CcSEcCtD
Lovastatin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000228	0.00108	CcSEcCtD
Lovastatin—Dizziness—Raloxifene—osteoporosis	0.000228	0.00108	CcSEcCtD
Lovastatin—Flatulence—Estradiol—osteoporosis	0.000227	0.00108	CcSEcCtD
Lovastatin—Vomiting—Estropipate—osteoporosis	0.000226	0.00107	CcSEcCtD
Lovastatin—Dysgeusia—Estradiol—osteoporosis	0.000226	0.00107	CcSEcCtD
Lovastatin—Dizziness—Ibandronate—osteoporosis	0.000225	0.00107	CcSEcCtD
Lovastatin—Rash—Estropipate—osteoporosis	0.000224	0.00106	CcSEcCtD
Lovastatin—Dermatitis—Estropipate—osteoporosis	0.000224	0.00106	CcSEcCtD
Lovastatin—Anorexia—Conjugated Estrogens—osteoporosis	0.000224	0.00106	CcSEcCtD
Lovastatin—Urticaria—Risedronate—osteoporosis	0.000223	0.00106	CcSEcCtD
Lovastatin—Back pain—Estradiol—osteoporosis	0.000223	0.00106	CcSEcCtD
Lovastatin—Headache—Estropipate—osteoporosis	0.000223	0.00106	CcSEcCtD
Lovastatin—Vomiting—Alendronate—osteoporosis	0.000223	0.00106	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000222	0.00105	CcSEcCtD
Lovastatin—Abdominal pain—Risedronate—osteoporosis	0.000222	0.00105	CcSEcCtD
Lovastatin—Body temperature increased—Risedronate—osteoporosis	0.000222	0.00105	CcSEcCtD
Lovastatin—Muscle spasms—Estradiol—osteoporosis	0.000221	0.00105	CcSEcCtD
Lovastatin—Rash—Alendronate—osteoporosis	0.000221	0.00105	CcSEcCtD
Lovastatin—Insomnia—Zoledronate—osteoporosis	0.000221	0.00105	CcSEcCtD
Lovastatin—Dermatitis—Alendronate—osteoporosis	0.000221	0.00105	CcSEcCtD
Lovastatin—Feeling abnormal—Pamidronate—osteoporosis	0.00022	0.00104	CcSEcCtD
Lovastatin—Headache—Alendronate—osteoporosis	0.000219	0.00104	CcSEcCtD
Lovastatin—Paraesthesia—Zoledronate—osteoporosis	0.000219	0.00104	CcSEcCtD
Lovastatin—Vomiting—Raloxifene—osteoporosis	0.000219	0.00104	CcSEcCtD
Lovastatin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000218	0.00104	CcSEcCtD
Lovastatin—Dyspnoea—Zoledronate—osteoporosis	0.000218	0.00103	CcSEcCtD
Lovastatin—Rash—Raloxifene—osteoporosis	0.000217	0.00103	CcSEcCtD
Lovastatin—Dermatitis—Raloxifene—osteoporosis	0.000217	0.00103	CcSEcCtD
Lovastatin—Vomiting—Ibandronate—osteoporosis	0.000217	0.00103	CcSEcCtD
Lovastatin—Tremor—Estradiol—osteoporosis	0.000216	0.00102	CcSEcCtD
Lovastatin—Headache—Raloxifene—osteoporosis	0.000216	0.00102	CcSEcCtD
Lovastatin—Rash—Ibandronate—osteoporosis	0.000215	0.00102	CcSEcCtD
Lovastatin—Dermatitis—Ibandronate—osteoporosis	0.000215	0.00102	CcSEcCtD
Lovastatin—Dyspepsia—Zoledronate—osteoporosis	0.000215	0.00102	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000214	0.00101	CcSEcCtD
Lovastatin—Ill-defined disorder—Estradiol—osteoporosis	0.000214	0.00101	CcSEcCtD
Lovastatin—Headache—Ibandronate—osteoporosis	0.000214	0.00101	CcSEcCtD
Lovastatin—Insomnia—Conjugated Estrogens—osteoporosis	0.000212	0.00101	CcSEcCtD
Lovastatin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000212	0.00101	CcSEcCtD
Lovastatin—Vomiting—Calcitriol—osteoporosis	0.000212	0.00101	CcSEcCtD
Lovastatin—Decreased appetite—Zoledronate—osteoporosis	0.000212	0.00101	CcSEcCtD
Lovastatin—Nausea—Estropipate—osteoporosis	0.000211	0.001	CcSEcCtD
Lovastatin—Abdominal pain—Pamidronate—osteoporosis	0.000211	0.001	CcSEcCtD
Lovastatin—Body temperature increased—Pamidronate—osteoporosis	0.000211	0.001	CcSEcCtD
Lovastatin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000211	0.001	CcSEcCtD
Lovastatin—Angioedema—Estradiol—osteoporosis	0.000211	0.000998	CcSEcCtD
Lovastatin—Rash—Calcitriol—osteoporosis	0.00021	0.000998	CcSEcCtD
Lovastatin—Fatigue—Zoledronate—osteoporosis	0.00021	0.000997	CcSEcCtD
Lovastatin—Dermatitis—Calcitriol—osteoporosis	0.00021	0.000997	CcSEcCtD
Lovastatin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000209	0.000993	CcSEcCtD
Lovastatin—Headache—Calcitriol—osteoporosis	0.000209	0.000991	CcSEcCtD
Lovastatin—Constipation—Zoledronate—osteoporosis	0.000209	0.000989	CcSEcCtD
Lovastatin—Pain—Zoledronate—osteoporosis	0.000209	0.000989	CcSEcCtD
Lovastatin—Nausea—Alendronate—osteoporosis	0.000208	0.000986	CcSEcCtD
Lovastatin—Malaise—Estradiol—osteoporosis	0.000208	0.000985	CcSEcCtD
Lovastatin—Hypersensitivity—Risedronate—osteoporosis	0.000207	0.000981	CcSEcCtD
Lovastatin—Vertigo—Estradiol—osteoporosis	0.000207	0.000981	CcSEcCtD
Lovastatin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000207	0.00098	CcSEcCtD
Lovastatin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000207	0.00098	CcSEcCtD
Lovastatin—Nausea—Raloxifene—osteoporosis	0.000205	0.00097	CcSEcCtD
Lovastatin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000204	0.000968	CcSEcCtD
Lovastatin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000204	0.000967	CcSEcCtD
Lovastatin—Fatigue—Conjugated Estrogens—osteoporosis	0.000203	0.00096	CcSEcCtD
Lovastatin—Nausea—Ibandronate—osteoporosis	0.000203	0.00096	CcSEcCtD
Lovastatin—Asthenia—Risedronate—osteoporosis	0.000202	0.000956	CcSEcCtD
Lovastatin—Feeling abnormal—Zoledronate—osteoporosis	0.000201	0.000953	CcSEcCtD
Lovastatin—Constipation—Conjugated Estrogens—osteoporosis	0.000201	0.000952	CcSEcCtD
Lovastatin—Pain—Conjugated Estrogens—osteoporosis	0.000201	0.000952	CcSEcCtD
Lovastatin—Gastrointestinal pain—Zoledronate—osteoporosis	0.0002	0.000946	CcSEcCtD
Lovastatin—Pruritus—Risedronate—osteoporosis	0.000199	0.000942	CcSEcCtD
Lovastatin—Nausea—Calcitriol—osteoporosis	0.000198	0.00094	CcSEcCtD
Lovastatin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000197	0.000935	CcSEcCtD
Lovastatin—Hypersensitivity—Pamidronate—osteoporosis	0.000197	0.000933	CcSEcCtD
Lovastatin—Chest pain—Estradiol—osteoporosis	0.000196	0.00093	CcSEcCtD
Lovastatin—Arthralgia—Estradiol—osteoporosis	0.000196	0.00093	CcSEcCtD
Lovastatin—Myalgia—Estradiol—osteoporosis	0.000196	0.00093	CcSEcCtD
Lovastatin—Anxiety—Estradiol—osteoporosis	0.000195	0.000927	CcSEcCtD
Lovastatin—Urticaria—Zoledronate—osteoporosis	0.000194	0.000919	CcSEcCtD
Lovastatin—Discomfort—Estradiol—osteoporosis	0.000194	0.000919	CcSEcCtD
Lovastatin—Abdominal pain—Zoledronate—osteoporosis	0.000193	0.000914	CcSEcCtD
Lovastatin—Body temperature increased—Zoledronate—osteoporosis	0.000193	0.000914	CcSEcCtD
Lovastatin—Diarrhoea—Risedronate—osteoporosis	0.000192	0.000911	CcSEcCtD
Lovastatin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000192	0.000911	CcSEcCtD
Lovastatin—Dry mouth—Estradiol—osteoporosis	0.000192	0.000909	CcSEcCtD
Lovastatin—Asthenia—Pamidronate—osteoporosis	0.000192	0.000909	CcSEcCtD
Lovastatin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000191	0.000904	CcSEcCtD
Lovastatin—Confusional state—Estradiol—osteoporosis	0.00019	0.000899	CcSEcCtD
Lovastatin—Pruritus—Pamidronate—osteoporosis	0.000189	0.000896	CcSEcCtD
Lovastatin—Anaphylactic shock—Estradiol—osteoporosis	0.000188	0.000891	CcSEcCtD
Lovastatin—Infection—Estradiol—osteoporosis	0.000187	0.000886	CcSEcCtD
Lovastatin—Urticaria—Conjugated Estrogens—osteoporosis	0.000187	0.000885	CcSEcCtD
Lovastatin—Dizziness—Risedronate—osteoporosis	0.000186	0.000881	CcSEcCtD
Lovastatin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000186	0.00088	CcSEcCtD
Lovastatin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000186	0.00088	CcSEcCtD
Lovastatin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000183	0.000869	CcSEcCtD
Lovastatin—Diarrhoea—Pamidronate—osteoporosis	0.000183	0.000866	CcSEcCtD
Lovastatin—Rash—Ethinyl Estradiol—osteoporosis	0.000182	0.000861	CcSEcCtD
Lovastatin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000182	0.000861	CcSEcCtD
Lovastatin—Headache—Ethinyl Estradiol—osteoporosis	0.000181	0.000856	CcSEcCtD
Lovastatin—Hypersensitivity—Zoledronate—osteoporosis	0.00018	0.000852	CcSEcCtD
Lovastatin—Vomiting—Risedronate—osteoporosis	0.000179	0.000847	CcSEcCtD
Lovastatin—Rash—Risedronate—osteoporosis	0.000177	0.00084	CcSEcCtD
Lovastatin—Dermatitis—Risedronate—osteoporosis	0.000177	0.000839	CcSEcCtD
Lovastatin—Dizziness—Pamidronate—osteoporosis	0.000177	0.000837	CcSEcCtD
Lovastatin—Headache—Risedronate—osteoporosis	0.000176	0.000835	CcSEcCtD
Lovastatin—Asthenia—Zoledronate—osteoporosis	0.000175	0.00083	CcSEcCtD
Lovastatin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000173	0.000821	CcSEcCtD
Lovastatin—Pruritus—Zoledronate—osteoporosis	0.000173	0.000818	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000171	0.000812	CcSEcCtD
Lovastatin—Nausea—Ethinyl Estradiol—osteoporosis	0.000171	0.000812	CcSEcCtD
Lovastatin—Insomnia—Estradiol—osteoporosis	0.00017	0.000806	CcSEcCtD
Lovastatin—Vomiting—Pamidronate—osteoporosis	0.00017	0.000805	CcSEcCtD
Lovastatin—Paraesthesia—Estradiol—osteoporosis	0.000169	0.0008	CcSEcCtD
Lovastatin—Asthenia—Conjugated Estrogens—osteoporosis	0.000169	0.000799	CcSEcCtD
Lovastatin—Rash—Pamidronate—osteoporosis	0.000168	0.000798	CcSEcCtD
Lovastatin—Dermatitis—Pamidronate—osteoporosis	0.000168	0.000798	CcSEcCtD
Lovastatin—Dyspnoea—Estradiol—osteoporosis	0.000168	0.000795	CcSEcCtD
Lovastatin—Headache—Pamidronate—osteoporosis	0.000167	0.000793	CcSEcCtD
Lovastatin—Diarrhoea—Zoledronate—osteoporosis	0.000167	0.000791	CcSEcCtD
Lovastatin—Nausea—Risedronate—osteoporosis	0.000167	0.000791	CcSEcCtD
Lovastatin—Pruritus—Conjugated Estrogens—osteoporosis	0.000166	0.000788	CcSEcCtD
Lovastatin—Dyspepsia—Estradiol—osteoporosis	0.000166	0.000785	CcSEcCtD
Lovastatin—Decreased appetite—Estradiol—osteoporosis	0.000163	0.000775	CcSEcCtD
Lovastatin—Fatigue—Estradiol—osteoporosis	0.000162	0.000769	CcSEcCtD
Lovastatin—Dizziness—Zoledronate—osteoporosis	0.000161	0.000765	CcSEcCtD
Lovastatin—Pain—Estradiol—osteoporosis	0.000161	0.000762	CcSEcCtD
Lovastatin—Constipation—Estradiol—osteoporosis	0.000161	0.000762	CcSEcCtD
Lovastatin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000161	0.000762	CcSEcCtD
Lovastatin—Nausea—Pamidronate—osteoporosis	0.000159	0.000752	CcSEcCtD
Lovastatin—Dizziness—Conjugated Estrogens—osteoporosis	0.000155	0.000737	CcSEcCtD
Lovastatin—Vomiting—Zoledronate—osteoporosis	0.000155	0.000735	CcSEcCtD
Lovastatin—Feeling abnormal—Estradiol—osteoporosis	0.000155	0.000735	CcSEcCtD
Lovastatin—Rash—Zoledronate—osteoporosis	0.000154	0.000729	CcSEcCtD
Lovastatin—Gastrointestinal pain—Estradiol—osteoporosis	0.000154	0.000729	CcSEcCtD
Lovastatin—Dermatitis—Zoledronate—osteoporosis	0.000154	0.000729	CcSEcCtD
Lovastatin—Headache—Zoledronate—osteoporosis	0.000153	0.000725	CcSEcCtD
Lovastatin—Vomiting—Conjugated Estrogens—osteoporosis	0.000149	0.000708	CcSEcCtD
Lovastatin—Urticaria—Estradiol—osteoporosis	0.000149	0.000708	CcSEcCtD
Lovastatin—Body temperature increased—Estradiol—osteoporosis	0.000149	0.000705	CcSEcCtD
Lovastatin—Abdominal pain—Estradiol—osteoporosis	0.000149	0.000705	CcSEcCtD
Lovastatin—Rash—Conjugated Estrogens—osteoporosis	0.000148	0.000702	CcSEcCtD
Lovastatin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000148	0.000702	CcSEcCtD
Lovastatin—Headache—Conjugated Estrogens—osteoporosis	0.000147	0.000698	CcSEcCtD
Lovastatin—Nausea—Zoledronate—osteoporosis	0.000145	0.000687	CcSEcCtD
Lovastatin—Nausea—Conjugated Estrogens—osteoporosis	0.00014	0.000662	CcSEcCtD
Lovastatin—Hypersensitivity—Estradiol—osteoporosis	0.000139	0.000657	CcSEcCtD
Lovastatin—Asthenia—Estradiol—osteoporosis	0.000135	0.00064	CcSEcCtD
Lovastatin—Pruritus—Estradiol—osteoporosis	0.000133	0.000631	CcSEcCtD
Lovastatin—Diarrhoea—Estradiol—osteoporosis	0.000129	0.00061	CcSEcCtD
Lovastatin—Dizziness—Estradiol—osteoporosis	0.000124	0.000589	CcSEcCtD
Lovastatin—Vomiting—Estradiol—osteoporosis	0.00012	0.000567	CcSEcCtD
Lovastatin—Rash—Estradiol—osteoporosis	0.000119	0.000562	CcSEcCtD
Lovastatin—Dermatitis—Estradiol—osteoporosis	0.000118	0.000562	CcSEcCtD
Lovastatin—Headache—Estradiol—osteoporosis	0.000118	0.000558	CcSEcCtD
Lovastatin—Nausea—Estradiol—osteoporosis	0.000112	0.000529	CcSEcCtD
Lovastatin—CYP3A5—Metabolism—CA2—osteoporosis	2.76e-05	0.000255	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—OXCT1—osteoporosis	2.76e-05	0.000255	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—P4HB—osteoporosis	2.76e-05	0.000255	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PGLS—osteoporosis	2.74e-05	0.000254	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPD2—osteoporosis	2.74e-05	0.000254	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PSMA2—osteoporosis	2.72e-05	0.000251	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PSMA5—osteoporosis	2.72e-05	0.000251	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GAPDH—osteoporosis	2.7e-05	0.00025	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ADCY5—osteoporosis	2.69e-05	0.000249	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TPI1—osteoporosis	2.69e-05	0.000249	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MGLL—osteoporosis	2.69e-05	0.000249	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CYP19A1—osteoporosis	2.69e-05	0.000249	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.69e-05	0.000248	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GPX1—osteoporosis	2.69e-05	0.000248	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IL6—osteoporosis	2.68e-05	0.000248	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PGLS—osteoporosis	2.68e-05	0.000248	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPD2—osteoporosis	2.68e-05	0.000248	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PKM—osteoporosis	2.66e-05	0.000246	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—FDPS—osteoporosis	2.66e-05	0.000246	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.65e-05	0.000245	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PKM—osteoporosis	2.64e-05	0.000244	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—FDPS—osteoporosis	2.64e-05	0.000244	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—RAP1A—osteoporosis	2.63e-05	0.000244	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ADCY5—osteoporosis	2.57e-05	0.000238	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CALCA—osteoporosis	2.53e-05	0.000234	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—P4HB—osteoporosis	2.53e-05	0.000234	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPD2—osteoporosis	2.52e-05	0.000233	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PGLS—osteoporosis	2.52e-05	0.000233	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ATIC—osteoporosis	2.51e-05	0.000232	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PNP—osteoporosis	2.51e-05	0.000232	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPD2—osteoporosis	2.5e-05	0.000231	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PGLS—osteoporosis	2.5e-05	0.000231	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ENO1—osteoporosis	2.49e-05	0.00023	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GAPDH—osteoporosis	2.48e-05	0.00023	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—MTHFR—osteoporosis	2.48e-05	0.000229	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PSMA5—osteoporosis	2.45e-05	0.000227	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PSMA2—osteoporosis	2.45e-05	0.000227	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ATIC—osteoporosis	2.45e-05	0.000226	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PNP—osteoporosis	2.45e-05	0.000226	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—RAP1A—osteoporosis	2.42e-05	0.000224	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—OXCT1—osteoporosis	2.39e-05	0.000221	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CA2—osteoporosis	2.39e-05	0.000221	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MTHFR—osteoporosis	2.37e-05	0.000219	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MGLL—osteoporosis	2.33e-05	0.000215	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ENO1—osteoporosis	2.32e-05	0.000215	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ATIC—osteoporosis	2.31e-05	0.000213	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PNP—osteoporosis	2.31e-05	0.000213	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KL—osteoporosis	2.3e-05	0.000213	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.3e-05	0.000212	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PSMA2—osteoporosis	2.29e-05	0.000212	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PSMA5—osteoporosis	2.29e-05	0.000212	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ATIC—osteoporosis	2.29e-05	0.000212	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PNP—osteoporosis	2.29e-05	0.000212	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—IDH2—osteoporosis	2.29e-05	0.000211	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CYP19A1—osteoporosis	2.29e-05	0.000211	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—ESR1—osteoporosis	2.26e-05	0.000209	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TGFB1—osteoporosis	2.25e-05	0.000208	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IRS2—osteoporosis	2.25e-05	0.000208	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ADCY5—osteoporosis	2.2e-05	0.000203	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.2e-05	0.000203	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GPX1—osteoporosis	2.19e-05	0.000202	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.15e-05	0.000199	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CA2—osteoporosis	2.13e-05	0.000197	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—OXCT1—osteoporosis	2.13e-05	0.000197	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ENO1—osteoporosis	2.13e-05	0.000197	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PSMA2—osteoporosis	2.1e-05	0.000194	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PSMA5—osteoporosis	2.1e-05	0.000194	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ACP5—osteoporosis	2.09e-05	0.000193	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—OXCT1—osteoporosis	2.08e-05	0.000193	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CA2—osteoporosis	2.08e-05	0.000193	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MGLL—osteoporosis	2.08e-05	0.000192	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MGLL—osteoporosis	2.03e-05	0.000188	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—MTHFR—osteoporosis	2.02e-05	0.000187	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP19A1—osteoporosis	1.99e-05	0.000184	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—POMC—osteoporosis	1.98e-05	0.000183	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—IDH2—osteoporosis	1.98e-05	0.000183	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IRS1—osteoporosis	1.96e-05	0.000182	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CA2—osteoporosis	1.96e-05	0.000181	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—OXCT1—osteoporosis	1.96e-05	0.000181	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.96e-05	0.000181	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ENO1—osteoporosis	1.95e-05	0.000181	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CA2—osteoporosis	1.95e-05	0.00018	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—OXCT1—osteoporosis	1.95e-05	0.00018	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TPI1—osteoporosis	1.94e-05	0.00018	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PSMA2—osteoporosis	1.93e-05	0.000178	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PSMA5—osteoporosis	1.93e-05	0.000178	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MGLL—osteoporosis	1.91e-05	0.000177	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MGLL—osteoporosis	1.9e-05	0.000175	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ADCY5—osteoporosis	1.87e-05	0.000173	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.86e-05	0.000172	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GPX1—osteoporosis	1.86e-05	0.000172	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP19A1—osteoporosis	1.86e-05	0.000172	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6R—osteoporosis	1.85e-05	0.000171	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—POMC—osteoporosis	1.85e-05	0.000171	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—P4HB—osteoporosis	1.83e-05	0.000169	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ACP5—osteoporosis	1.81e-05	0.000167	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ADCY5—osteoporosis	1.8e-05	0.000167	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GAPDH—osteoporosis	1.79e-05	0.000166	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.79e-05	0.000165	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.79e-05	0.000165	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—IDH2—osteoporosis	1.77e-05	0.000163	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—RAP1A—osteoporosis	1.75e-05	0.000162	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SPP1—osteoporosis	1.74e-05	0.000161	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FDPS—osteoporosis	1.74e-05	0.000161	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PKM—osteoporosis	1.74e-05	0.000161	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—IDH2—osteoporosis	1.73e-05	0.00016	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—MTHFR—osteoporosis	1.72e-05	0.000159	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP19A1—osteoporosis	1.7e-05	0.000157	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TPI1—osteoporosis	1.68e-05	0.000156	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.66e-05	0.000154	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PGLS—osteoporosis	1.65e-05	0.000153	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPD2—osteoporosis	1.65e-05	0.000153	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ADCY5—osteoporosis	1.63e-05	0.00015	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—IDH2—osteoporosis	1.63e-05	0.00015	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP27A1—osteoporosis	1.62e-05	0.00015	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GPX1—osteoporosis	1.62e-05	0.00015	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ACP5—osteoporosis	1.62e-05	0.000149	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—POMC—osteoporosis	1.62e-05	0.000149	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—IDH2—osteoporosis	1.61e-05	0.000149	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.6e-05	0.000148	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.59e-05	0.000147	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.59e-05	0.000147	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—P4HB—osteoporosis	1.58e-05	0.000146	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ACP5—osteoporosis	1.58e-05	0.000146	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IRS2—osteoporosis	1.58e-05	0.000146	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.56e-05	0.000144	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GAPDH—osteoporosis	1.55e-05	0.000144	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—LEP—osteoporosis	1.54e-05	0.000143	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.53e-05	0.000141	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ADCY5—osteoporosis	1.52e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.52e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—RAP1A—osteoporosis	1.51e-05	0.00014	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GPX1—osteoporosis	1.51e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ATIC—osteoporosis	1.51e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PNP—osteoporosis	1.51e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TPI1—osteoporosis	1.5e-05	0.000139	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—MTHFR—osteoporosis	1.5e-05	0.000138	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ACP5—osteoporosis	1.49e-05	0.000137	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.49e-05	0.000137	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.48e-05	0.000137	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ACP5—osteoporosis	1.47e-05	0.000136	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ESR1—osteoporosis	1.47e-05	0.000136	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TPI1—osteoporosis	1.47e-05	0.000136	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.46e-05	0.000135	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—P4HB—osteoporosis	1.41e-05	0.000131	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ENO1—osteoporosis	1.41e-05	0.000131	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—MTHFR—osteoporosis	1.4e-05	0.000129	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PSMA5—osteoporosis	1.39e-05	0.000129	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PSMA2—osteoporosis	1.39e-05	0.000129	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ADCY5—osteoporosis	1.39e-05	0.000129	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GAPDH—osteoporosis	1.39e-05	0.000128	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GPX1—osteoporosis	1.39e-05	0.000128	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TPI1—osteoporosis	1.38e-05	0.000128	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—P4HB—osteoporosis	1.38e-05	0.000128	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IRS1—osteoporosis	1.38e-05	0.000127	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—POMC—osteoporosis	1.37e-05	0.000127	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TPI1—osteoporosis	1.37e-05	0.000127	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GAPDH—osteoporosis	1.35e-05	0.000125	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—RAP1A—osteoporosis	1.35e-05	0.000125	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—POMC—osteoporosis	1.32e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.32e-05	0.000122	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—RAP1A—osteoporosis	1.32e-05	0.000122	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—P4HB—osteoporosis	1.3e-05	0.00012	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6R—osteoporosis	1.29e-05	0.00012	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—P4HB—osteoporosis	1.29e-05	0.000119	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—OXCT1—osteoporosis	1.28e-05	0.000119	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CA2—osteoporosis	1.28e-05	0.000119	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MTHFR—osteoporosis	1.28e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ADCY5—osteoporosis	1.28e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GAPDH—osteoporosis	1.28e-05	0.000118	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF1—osteoporosis	1.27e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GPX1—osteoporosis	1.27e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GAPDH—osteoporosis	1.26e-05	0.000117	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MGLL—osteoporosis	1.25e-05	0.000116	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000115	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—RAP1A—osteoporosis	1.23e-05	0.000114	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ENO1—osteoporosis	1.22e-05	0.000113	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PSMA2—osteoporosis	1.21e-05	0.000111	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PSMA5—osteoporosis	1.21e-05	0.000111	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—POMC—osteoporosis	1.2e-05	0.000111	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.18e-05	0.000109	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—osteoporosis	1.18e-05	0.000109	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MTHFR—osteoporosis	1.17e-05	0.000109	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.13e-05	0.000104	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—POMC—osteoporosis	1.12e-05	0.000103	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—osteoporosis	1.09e-05	0.000101	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ENO1—osteoporosis	1.09e-05	0.000101	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—osteoporosis	1.09e-05	0.000101	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PSMA2—osteoporosis	1.08e-05	9.95e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PSMA5—osteoporosis	1.08e-05	9.95e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.07e-05	9.93e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ENO1—osteoporosis	1.07e-05	9.86e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—IDH2—osteoporosis	1.06e-05	9.83e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PSMA2—osteoporosis	1.05e-05	9.71e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PSMA5—osteoporosis	1.05e-05	9.71e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—POMC—osteoporosis	1.02e-05	9.46e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ENO1—osteoporosis	1e-05	9.29e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.99e-06	9.24e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ENO1—osteoporosis	9.96e-06	9.21e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PSMA5—osteoporosis	9.9e-06	9.15e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PSMA2—osteoporosis	9.9e-06	9.15e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PSMA2—osteoporosis	9.81e-06	9.07e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PSMA5—osteoporosis	9.81e-06	9.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP19A1—osteoporosis	9.78e-06	9.04e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ACP5—osteoporosis	9.72e-06	8.99e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—POMC—osteoporosis	9.39e-06	8.68e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ADCY5—osteoporosis	9.23e-06	8.53e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GPX1—osteoporosis	9.2e-06	8.5e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TPI1—osteoporosis	9.04e-06	8.36e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP19A1—osteoporosis	8.73e-06	8.07e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP19A1—osteoporosis	8.52e-06	7.88e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—P4HB—osteoporosis	8.5e-06	7.86e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTHFR—osteoporosis	8.49e-06	7.85e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GAPDH—osteoporosis	8.34e-06	7.71e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—osteoporosis	8.22e-06	7.6e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—RAP1A—osteoporosis	8.12e-06	7.51e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.03e-06	7.42e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ADCY5—osteoporosis	7.99e-06	7.39e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPX1—osteoporosis	7.96e-06	7.36e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP19A1—osteoporosis	7.96e-06	7.36e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—osteoporosis	7.66e-06	7.08e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—osteoporosis	7.64e-06	7.06e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTHFR—osteoporosis	7.35e-06	6.8e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ADCY5—osteoporosis	7.13e-06	6.6e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPX1—osteoporosis	7.11e-06	6.57e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ADCY5—osteoporosis	6.96e-06	6.44e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPX1—osteoporosis	6.94e-06	6.42e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—POMC—osteoporosis	6.79e-06	6.28e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ENO1—osteoporosis	6.57e-06	6.07e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ADCY5—osteoporosis	6.56e-06	6.07e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTHFR—osteoporosis	6.56e-06	6.07e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPX1—osteoporosis	6.54e-06	6.05e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ADCY5—osteoporosis	6.5e-06	6.01e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPX1—osteoporosis	6.48e-06	5.99e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PSMA5—osteoporosis	6.47e-06	5.98e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PSMA2—osteoporosis	6.47e-06	5.98e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTHFR—osteoporosis	6.4e-06	5.92e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTHFR—osteoporosis	6.03e-06	5.58e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTHFR—osteoporosis	5.98e-06	5.53e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—POMC—osteoporosis	5.88e-06	5.44e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—osteoporosis	5.76e-06	5.32e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.25e-06	4.85e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—POMC—osteoporosis	5.25e-06	4.85e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—POMC—osteoporosis	5.12e-06	4.74e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—POMC—osteoporosis	4.83e-06	4.46e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—POMC—osteoporosis	4.78e-06	4.42e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADCY5—osteoporosis	4.29e-06	3.97e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPX1—osteoporosis	4.28e-06	3.95e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTHFR—osteoporosis	3.95e-06	3.65e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—POMC—osteoporosis	3.16e-06	2.92e-05	CbGpPWpGaD
